Syneos Health Reports First Quarter 2022 Results
29. April 2022 06:24 ET
|
Syneos Health, Inc.
Highlights Revenue for the first quarter of $1,336.3 million increased 10.5% on a reported basis and 11.7% on a constant currency basis year-over-year.Clinical Solutions net new business...
Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs
19. April 2022 08:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior...
Syneos Health Schedules First Quarter 2022 Earnings Call for Friday, April 29th, 2022
11. April 2022 16:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health Reports Fourth Quarter and Full Year 2021 Results
17. Februar 2022 06:10 ET
|
Syneos Health, Inc.
Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses,...
Syneos Health Schedules Fourth Quarter and Full Year 2021 Earnings Call for Thursday, February 17th, 2022
01. Februar 2022 07:26 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health Appoints Two New Independent Directors
18. Januar 2022 06:16 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
11. Januar 2022 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...
Syneos Health to Present at the 40th Annual J.P. Morgan Healthcare Conference
04. Januar 2022 09:06 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success,...
Syneos Health Releases 2022 Health Trends
21. Dezember 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released 2022 Health Trends: Insights for...
Syneos Health to Present at Upcoming Investor Conferences
11. November 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that the Company is scheduled...